Down-regulation of CD46 by Piliated Neisseria gonorrhoeae

Journal of Experimental Medicine

Volumn 198, Issue 9, 2003, Pages 1313-1322

  Gill, Darcy B ^a   Koomey, Michael ^b   Cannon, Janne G ^c   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

PilE; PilT; Pilus retraction; Protein shedding; Type IV pilus

Indexed keywords

BACTERIAL PROTEIN; CELL SURFACE PROTEIN; COMPLEMENT; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; PILIN; PROTEIN PILT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ADHERENCE; BACTERIUM PILUS; CELL ADHESION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; GENE REPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NEISSERIA GONORRHOEAE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, CD46; CELL LINE; DOWN-REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; NEISSERIA GONORRHOEAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0242695542     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031159     Document Type: Article

References (63)

1. Lindahl, G., U. Sjobring, and E. Johnsson. 2000. Human complement regulators: a major target for pathogenic microorganisms. Curr. Opin. Immunol. 12:44-51.
2. Liszewski, M.K., T.W. Post, and J.P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455.
3. Naniche, D., G. Varior-Krishnan, F. Cervoni, T.F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
4. Dorig, R.E., A. Marcil, A. Chopra, and C.D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:295-305.
5. Okada, N., M.K. Liszewski, J.P. Atkinson, and M. Caparon. 1995. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA. 92:2489-2493.
6. Santoro, F., P.E. Kennedy, G. Locatelli, M.S. Malnati, E.A. Berger, and P. Lusso. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell. 99:817-827.
7. Kallstrom, H., M.K. Liszewski, J.P. Atkinson, and A.B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647.
8. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:228-231. (published erratum appears in Science. 1997. 275:1053)
9. Karp, C.L., M. Wysocka, L.M. Wahl, J.M. Ahearn, P.J. Cuomo, B. Sherry, G. Trinchieri, and D.E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:228-231. (published erratum appears in Science. 1997. 275:1053)
10. Hirano, A., Z. Yang, Y. Katayama, J. Korte-Sarfaty, and T.C. Wong. 1999. Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domains. J. Virol. 73:4776-4785.
11. Katayama, Y., A. Hirano, and T.C. Wong. 2000. Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J. Virol. 74:1252-1257.
12. Yant, S., A. Hirano, and T.C. Wong. 1997. Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection. J. Virol. 71:766-770.
13. Krantic, S., C. Gimenez, and C. Rabourdin-Combe. 1995. Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J. Gen. Virol. 76:2793-2800.
14. Naniche, D., T.F. Wild, C. Rabourdin-Combe, and D. Gerlier. 1993. Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J. Gen. Virol. 74:1073-1079.
15. Schneider-Schaulies, J., J.J. Schnorr, U. Brinckmann, L.M. Dunster, K. Baczko, U.G. Liebert, S. Schneider-Schaulies, and V. ter Meulen. 1995. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. USA. 92:3943-3947.
16. Schneider-Schaulies, J., L.M. Dunster, F. Kobune, B. Rima, and V. ter Meulen. 1995. Differential downregulation of CD46 by measles virus strains. J. Virol. 69:7257-7259.
17. Schneider-Schaulies, J., J.J. Schnorr, J. Schlender, L.M. Dunster, S. Schneider-Schaulies, and V. ter Meulen. 1996. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. J. Virol. 70:255-263.
18. Manchester, M., A. Valsamakis, R. Kaufman, M.K. Liszewski, J. Alvarez, J.P. Atkinson, D.M. Lublin, and M.B. Oldstone. 1995. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc. Natl. Acad. Sci. USA. 92:2303-2307.
19. Seya, T., M. Kurita, T. Hara, K. Iwata, T. Semba, M. Hatanaka, M. Matsumoto, Y. Yanagi, S. Ueda, and S. Nagasawa. 1995. Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Immunology. 84:619-625.
20. Devaux, P., and D. Gerlier. 1997. Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding. J. Virol. 71:1679-1682. (published erratum appears in J. Virol. 1997. 71:4186)
21. Devaux, P., and D. Gerlier. 1997. Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding. J. Virol. 71:1679-1682. (published erratum appears in J. Virol. 1997. 71:4186)
22. Christiansen, D., P. Devaux, B. Reveil, A. Evlashev, B. Horvat, J. Lamy, C. Rabourdin-Combe, J.H. Cohen, and D. Gerlier. 2000. Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J. Virol. 74:4672-4678.
23. Tishon, A., M. Manchester, F. Scheiflinger, and M.B. Oldstone. 1996. A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs. Nat. Med. 2:1250-1254.
24. Schnorr, J.J., L.M. Dunster, R. Nanan, J. Schneider-Schaulies, S. Schneider-Schaulies, and V. ter Meulen. 1995. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur. J. Immunol. 25:976-984.
25. Merz, A.J., and M. So. 2000. Interactions of pathogenic neisseriae with epithelial cell membranes. Annu. Rev. Cell Dev. Biol. 16:423-457.
26. Koomey, M., E.C. Gotschlich, K. Kobbins, S. Bergstrom, and J. Swanson. 1987. Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics. 117:391-398.
27. Mehr, I.J., and H.S. Seifert. 1998. Differential roles of homologous recombination pathways in Neisseria gonorrhoeae pilin antigenic variation, DNA transformation and DNA repair. Mol. Microbiol. 30:697-710.
28. Zhang, Q.Y., D. DeRyckere, P. Lauer, and J.M. Koomey, 1992. Gene conversion in Neisseria gonorrhoeae: evidence for its role in pilus antigenic variation. Proc. Natl. Acad. Sci. USA. 89:5366-5370.
29. Virji, M., and J.E. Heckels. 1984. The role of common and type-specific pilus antigenic domains in adhesion and virulence of gonococci for human epithelial cells. J. Gen. Microbiol. 130:1089-1095.
30. Rudel, T., J.P. van Putten, C.P. Gibbs, R. Haas, and T.F. Meyer. 1992. Interaction of two variable proteins (PilE and PilC) required for pilus-mediated adherence of Neisseria gonorrhoeae to human epithelial cells. Mol. Microbiol. 6:3439-3450.
31. Jonsson, A.B., D. Ilver, P. Falk, J. Pepose, and S. Normark. 1994. Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue. Mol. Microbiol. 13:403-416.
32. Rudel, T., I. Scheurerpflug, and T.F. Meyer. 1995. Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature. 373:357-359.
33. Rahman, M., H. Kallstrom, S. Normark, and A.B. Jonsson. 1997. PilC of pathogenic Neisseria is associated with the bacterial cell surface. Mol. Microbiol. 25:11-25.
34. Jonsson, A.B., G. Nyberg, and S. Normark. 1991. Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J. 10:477-488.
35. Jonsson, A.B., J. Pfeifer, and S. Normark. 1992. Neisseria gonorrhoeae PilC expression provides a selective mechanism for structural diversity of pili. Proc. Natl. Acad. Sci. USA. 89:3204-3208.
36. Rudel, T., D. Facius, R. Barten, I. Scheuerpflug, E. Nonnenmacher, and T.F. Meyer. 1995. Role of pili and the phase-variable PilC protein in natural competence for transformation of Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. USA. 92:7986-7990.
37. Wolfgang, M., J.P. van Putten, S.F. Hayes, D. Dorward, and M. Koomey. 2000. Components and dynamics of fiber formation define a ubiquitous biogenesis pathway for bacterial pili. EMBO J. 19:6408-6418.
38. Tobiason, D.M., and H.S. Seifert. 2001. Inverse relationship between pilus-mediated gonococcal adherence and surface expression of the pilus receptor, CD46. Microbiol. 147:2333-2340.
39. Kallstrom, H., M.S. Islam, P.O. Berggren, and A.B. Jonsson. 1998. Cell signaling by the type IV pili of pathogenic Neisseria. J. Biol. Chem. 273:21777-21782.
40. Lee, S.W., R.A. Bonnah, D.L. Higashi, J.P. Atkinson, S.L. Milgram, and M. So. 2002. CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J. Cell Biol. 156:951-957.
41. Kallstrom, H., D. Blackmer Gill, B. Albiger, M.K. Liszewski, J.P. Atkinson, and A.B. Jonsson. 2001. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell. Microbiol. 3:133-143.
42. Dunn, K.L., M. Virji, and E.R. Moxon. 1995. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb. Pathog. 18:81-96.
43. McGee, Z.A., A.P. Johnson, and D. Taylor-Robinson. 1981. Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143:413-422.
44. Ayala, P., L. Lin, S. Hopper, M. Fukuda, and M. So. 1998. Infection of epithelial cells by pathogenic neisseriae reduces the levels of multiple lysosomal constituents. Infect. Immun. 66:5001-5007.
45. Merz, A.J., C.A. Enns, and M. So. 1999. Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells. Mol. Microbiol. 32:1316-1332.
46. Merz, A.J., M. So, and M.P. Sheetz. 2000. Pilus retraction powers bacterial twitching motility. Nature. 407:98-102.
47. Wolfgang, M., P. Lauer, H.S. Park, L. Brossay, J. Hebert, and M. Koomey. 1998. PilT mutations lead to simultaneous defects in competence for natural transformation and twitching motility in piliated Neisseria gonorrhoeae. Mol. Microbiol. 29:321-330.
48. Swanson, J., S.J. Kraus, and E.C. Gotschlich. 1971. Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns. J. Exp. Med. 134:886-906.
49. Cohen, M.S., J.G. Cannon, A.E. Jerse, L.M. Charniga, S.F. Isbey, and L.G. Whicker. 1994. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169:532-537.
50. Jerse, A.E., M.S. Cohen, P.M. Drown, L.G. Whicker, S.F. Isbey, H.S. Seifert, and J.G. Cannon. 1994. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179:911-920.
51. Hamrick, T.S., J.A. Dempsey, M.S. Cohen, and J.G. Cannon. 2001. Antigenic variation of gonococcal pilin expression in vivo: analysis of the strain FA1090 pilin repertoire and identification of the pilS gene copies recombining with pilE during experimental human infection. Microbiol. 147:839-849.
52. Liszewski, M.K., M. Leung, W. Cui, V. Bala Subramanian, J. Parkinson, P.N. Barlow, M. Manchester, and J.P. Atkinson. 2000. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 275:37692-37701.
53. Liszewski, M.K., and J.P. Atkinson. 1996. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. J. Immunol. 156:4415-4421.
54. Wang, G., M.K. Liszewski, A.C. Chan, and J.P. Atkinson. 2000. Membrane cofactor protein (MCP; CD46) isoform-specific tyrosine phosphorylation. J. Immunol. 164:1839-1846.
55. Liszewsi, M.K., and J.P. Atkinson. 1998. Membrane cofactor protein (CD46) and decay-accelerating factor (CD55). In The Complement System. K. Rother, G.O. Till, and G.M. Hansch, editors. Springer Velag Berlin, Heidelberg. 146-162.
56. Brodbeck, W.G., C. Mold, J.P. Atkinson, and M.E. Medof. 2000. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J. Immunol. 165:3999-4006.
57. Park, H.S., M. Wolfgang, and M. Koomey. 2002. Modification of type IV pilus-associated epithelial cell adherence and multicellular behavior by the PilU protein of Neisseria gonorrhoeae. Infect. Immun. 70:3891-3903.
58. Winther-Larsen, H.C., F.T. Hegge, M. Wolfgang, S.F. Hayes, J.P. van Putten, and M. Koomey. 2001. Neisseria gonorrhoeae PilV, a type IV pilus-associated protein essential to human epithelial cell adherence. Proc. Natl. Acad. Sci. USA. 98:15276-15281.
59. Merz, A.J., and M. So. 1997. Attachment of piliated, Opa- and Opc-gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins. Infect. Immun. 65:4341-4349.
60. Pujol, C., E. Eugene, M. Marceau, and X. Nassif. 1999. The meningococcal PilT protein is required for induction of intimate attachment to epithelial cells following pilus-mediated adhesion. Proc. Natl. Acad. Sci. USA. 96:4017-4022.
61. Galbraith, S.E., A. Tiwari, M.D. Baron, B.T. Lund, T. Barrett, and S.L. Cosby. 1998. Morbillivirus downregulation of CD46. J. Virol. 72:10292-10297.
62. Seifert, H.S. 1996. Questions about gonococcal pilus phase and antigenic variation. Mol. Microbiol. 21:433-440.
63. Nassif, X., C. Pujol, P. Morand, and E. Eugene. 1999. Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol. Microbiol. 32:1124-1132.